JP7472162B2 - 光照射装置 - Google Patents
光照射装置 Download PDFInfo
- Publication number
- JP7472162B2 JP7472162B2 JP2021556330A JP2021556330A JP7472162B2 JP 7472162 B2 JP7472162 B2 JP 7472162B2 JP 2021556330 A JP2021556330 A JP 2021556330A JP 2021556330 A JP2021556330 A JP 2021556330A JP 7472162 B2 JP7472162 B2 JP 7472162B2
- Authority
- JP
- Japan
- Prior art keywords
- light
- irradiated
- irradiation device
- present
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000758 substrate Substances 0.000 claims description 28
- 230000035515 penetration Effects 0.000 claims description 25
- 208000027418 Wounds and injury Diseases 0.000 description 63
- 206010052428 Wound Diseases 0.000 description 61
- 210000003491 skin Anatomy 0.000 description 59
- 244000052769 pathogen Species 0.000 description 31
- 241000894006 Bacteria Species 0.000 description 25
- 210000004207 dermis Anatomy 0.000 description 22
- 210000002615 epidermis Anatomy 0.000 description 22
- 230000001954 sterilising effect Effects 0.000 description 16
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 230000029663 wound healing Effects 0.000 description 11
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000001678 irradiating effect Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 239000003642 reactive oxygen metabolite Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 210000002865 immune cell Anatomy 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000036560 skin regeneration Effects 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000035901 Ischaemic ulcer Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000037456 inflammatory mechanism Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
- H05B47/10—Controlling the light source
- H05B47/155—Coordinated control of two or more light sources
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
- H05B47/10—Controlling the light source
- H05B47/16—Controlling the light source by timing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0629—Sequential activation of light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02B—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
- Y02B20/00—Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps
- Y02B20/40—Control techniques providing energy savings, e.g. smart controller or presence detection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Radiation-Therapy Devices (AREA)
- Non-Portable Lighting Devices Or Systems Thereof (AREA)
- Led Device Packages (AREA)
Description
Claims (6)
- 青色波長帯域の第1の光を照射する複数の第1の光源と、
赤色乃至近赤外線波長帯域の第2の光を照射する複数の第2の光源と、
前記複数の第1の光源及び前記複数の第2の光源が実装される基板と、
前記複数の第1及び複数の第2の光源を制御する制御部と、を含み、
前記基板は、凹状部分に相当する第1の領域と、前記第1の領域を囲み凸状部分に相当する第2の領域と、前記第1の領域と前記第2の領域とを繋ぐ傾斜面に相当する第3の領域と、を有し、
前記複数の第1の光源は、前記第1の領域及び前記第3の領域に配置され、前記第2の光源は、前記第2の領域に配置され、
前記第1の光及び前記第2の光は、波長に応じて互いに異なる皮膚侵入深さを有し、前記第1の光の皮膚侵入深さと前記第2の光の皮膚侵入深さとの差は1.8mm以上である光照射装置。 - 前記第1の光は0.8mm以上の皮膚侵入深さを有し、前記第2の光は4.3mm以上の皮膚侵入深さを有する、請求項1に記載の光照射装置。
- 前記第1の光は第1の時間照射され、前記第2の光は、前記第1の時間より長い第2の時間照射される、請求項1に記載の光照射装置。
- 前記第2の光は、前記第1の光の照射が終了する前に照射が開始され、前記第1の時間と前記第2の時間の少なくとも一部は、互いに重畳する期間を有する、請求項3に記載の光照射装置。
- 前記第1の光は不連続的に照射され、
前記第2の光は連続的に照射される、請求項4に記載の光照射装置。 - 前記第1の光の前記皮膚への照射範囲は、前記第2の光の前記皮膚への照射範囲より小さい、請求項1に記載の光照射装置。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962820493P | 2019-03-19 | 2019-03-19 | |
US62/820,493 | 2019-03-19 | ||
US16/821,024 | 2020-03-17 | ||
US16/821,024 US11992698B2 (en) | 2019-03-19 | 2020-03-17 | Light irradiation device |
PCT/KR2020/003692 WO2020190022A1 (ko) | 2019-03-19 | 2020-03-18 | 광 조사 장치 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022526285A JP2022526285A (ja) | 2022-05-24 |
JPWO2020190022A5 JPWO2020190022A5 (ja) | 2023-03-28 |
JP7472162B2 true JP7472162B2 (ja) | 2024-04-22 |
Family
ID=72514088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021556330A Active JP7472162B2 (ja) | 2019-03-19 | 2020-03-18 | 光照射装置 |
Country Status (6)
Country | Link |
---|---|
US (1) | US11992698B2 (ja) |
EP (1) | EP3943151A4 (ja) |
JP (1) | JP7472162B2 (ja) |
KR (1) | KR20210129711A (ja) |
WO (1) | WO2020190022A1 (ja) |
ZA (3) | ZA202106885B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10525275B2 (en) | 2015-07-28 | 2020-01-07 | Photonmd, Inc. | Systems and methods for phototherapeutic modulation of nitric oxide |
US20210128935A1 (en) | 2015-07-28 | 2021-05-06 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
US12011611B2 (en) | 2020-03-19 | 2024-06-18 | Know Bio, Llc | Illumination devices for inducing biological effects |
US11986666B2 (en) | 2020-03-19 | 2024-05-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
WO2022101057A1 (en) * | 2020-11-10 | 2022-05-19 | Signify Holding B.V. | Render of disinfectant light with ir and uv components |
US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007514459A (ja) | 2003-09-30 | 2007-06-07 | キュアライト・リミテッド | 皮膚疾患の光治療処置 |
JP2011509122A (ja) | 2008-01-08 | 2011-03-24 | オレゴン エステティック テクノロジーズ | 皮膚治療システム |
JP2016511672A (ja) | 2013-03-01 | 2016-04-21 | クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. | 光線療法装置、方法および使用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138717B1 (ko) * | 2009-11-17 | 2012-04-24 | 재단법인 철원플라즈마 산업기술연구원 | 피부 진단 및 치료 장치와 이를 이용한 피부 진단 및 치료 방법 |
EP2383017A1 (en) | 2010-04-28 | 2011-11-02 | Koninklijke Philips Electronics N.V. | Phototherapy device |
KR20120069588A (ko) | 2010-12-20 | 2012-06-28 | 주식회사 루트로닉 | 광 치료장치 및 이의 제어방법 |
US9950190B2 (en) * | 2011-07-03 | 2018-04-24 | Medical Quant Ltd | Device and method of treating fungal nail infections |
CA2854923C (en) | 2011-11-08 | 2021-10-19 | Biophotas, Inc. | Shapeable light therapy device and method |
KR101598665B1 (ko) | 2013-09-23 | 2016-02-29 | 박행배 | 피부개선 및 발모용 광 요법 장치 |
US20160016001A1 (en) * | 2014-02-28 | 2016-01-21 | Klox Technologies Inc. | Phototherapeutic device, method and use |
KR101561448B1 (ko) * | 2014-06-05 | 2015-10-30 | 동방국제지주 주식회사 | 미립자를 포함하는 도광판을 이용한 광치료기 |
GB2548012B (en) | 2016-02-26 | 2021-04-28 | Nanoco Technologies Ltd | Phototherapy mask with quantum dot phosphors |
EP3570729A1 (en) | 2017-01-18 | 2019-11-27 | Koninklijke Philips N.V. | Detecting erythema caused by wearable devices |
-
2020
- 2020-03-17 US US16/821,024 patent/US11992698B2/en active Active
- 2020-03-18 KR KR1020217031097A patent/KR20210129711A/ko unknown
- 2020-03-18 JP JP2021556330A patent/JP7472162B2/ja active Active
- 2020-03-18 WO PCT/KR2020/003692 patent/WO2020190022A1/ko unknown
- 2020-03-18 EP EP20773884.0A patent/EP3943151A4/en active Pending
-
2021
- 2021-09-17 ZA ZA2021/06885A patent/ZA202106885B/en unknown
-
2022
- 2022-12-07 ZA ZA2022/13282A patent/ZA202213282B/en unknown
-
2023
- 2023-04-26 ZA ZA2023/04878A patent/ZA202304878B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007514459A (ja) | 2003-09-30 | 2007-06-07 | キュアライト・リミテッド | 皮膚疾患の光治療処置 |
JP2011509122A (ja) | 2008-01-08 | 2011-03-24 | オレゴン エステティック テクノロジーズ | 皮膚治療システム |
JP2016511672A (ja) | 2013-03-01 | 2016-04-21 | クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. | 光線療法装置、方法および使用 |
Also Published As
Publication number | Publication date |
---|---|
US11992698B2 (en) | 2024-05-28 |
JP2022526285A (ja) | 2022-05-24 |
WO2020190022A1 (ko) | 2020-09-24 |
KR20210129711A (ko) | 2021-10-28 |
EP3943151A1 (en) | 2022-01-26 |
US20200298016A1 (en) | 2020-09-24 |
ZA202304878B (en) | 2024-03-27 |
ZA202106885B (en) | 2023-02-22 |
EP3943151A4 (en) | 2022-12-07 |
ZA202213282B (en) | 2023-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7472162B2 (ja) | 光照射装置 | |
US11938236B2 (en) | Medical dressing | |
US10532219B2 (en) | Apparatus for treatment of wounds and skin medical conditions at a predetermined skin area of a human body | |
EP2361116B1 (en) | Irradiation apparatus | |
US6960201B2 (en) | Method for the prevention and treatment of skin and nail infections | |
Caetano et al. | Phototherapy improves healing of chronic venous ulcers | |
US20050288746A1 (en) | Device for treating infants with light | |
KR101598665B1 (ko) | 피부개선 및 발모용 광 요법 장치 | |
JPWO2020090919A5 (ja) | ||
WO2007123859A2 (en) | Method and device to inactivate and kill cells and organisms that are undesirable | |
US20230045570A1 (en) | Light radiation device for medical treatment | |
OA20368A (en) | Light emission device | |
RU2539535C1 (ru) | Матричный лазерный излучатель для физиотерапевтического аппарата | |
CN108543231B (zh) | 一种可降解的多光谱发光植入物 | |
WO2014177837A1 (en) | Photodynamic therapy | |
KR101769392B1 (ko) | 파장형 led조사기구 | |
US20150029307A1 (en) | Method and device for improved ulcer treatment | |
KR100633430B1 (ko) | 근적외선을 이용한 내강(內腔)치료기 | |
US20220288413A1 (en) | Devices and methods for illuminating tissue to induce biological effects | |
KR200345466Y1 (ko) | 근적외선 발광다이오드를 이용한 내강치료기 | |
Karaim | Light that can cure you | |
KR20230124184A (ko) | 구강점막 병변 치료기 | |
Irvine | BIOPHYSICAL AGENTS IN WOUND CARE | |
WO2011130620A2 (en) | Method and device for improved ulcer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230317 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230317 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240312 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240410 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7472162 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |